Hotchkis & Wiley Capital Management LLC Buys 50,030 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Hotchkis & Wiley Capital Management LLC lifted its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 128.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 89,010 shares of the medical instruments supplier’s stock after purchasing an additional 50,030 shares during the period. Hotchkis & Wiley Capital Management LLC owned 2.63% of Utah Medical Products worth $5,956,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Martingale Asset Management L P raised its stake in shares of Utah Medical Products by 5.3% during the 3rd quarter. Martingale Asset Management L P now owns 3,968 shares of the medical instruments supplier’s stock worth $266,000 after purchasing an additional 201 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in shares of Utah Medical Products by 102.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock worth $75,000 after acquiring an additional 566 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Utah Medical Products by 72.1% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 10,337 shares of the medical instruments supplier’s stock worth $692,000 after acquiring an additional 4,330 shares during the last quarter. Minerva Advisors LLC increased its holdings in shares of Utah Medical Products by 461.8% during the 3rd quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock worth $2,818,000 after acquiring an additional 34,794 shares during the last quarter. Finally, Seizert Capital Partners LLC increased its holdings in shares of Utah Medical Products by 58.3% during the 3rd quarter. Seizert Capital Partners LLC now owns 5,736 shares of the medical instruments supplier’s stock worth $384,000 after acquiring an additional 2,112 shares during the last quarter. Institutional investors own 69.60% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th.

Utah Medical Products Trading Down 0.8 %

UTMD stock opened at $63.74 on Friday. The firm has a market capitalization of $216.08 million, a PE ratio of 14.93 and a beta of 0.08. Utah Medical Products, Inc. has a 1-year low of $63.38 and a 1-year high of $87.00. The business’s 50 day simple moving average is $65.52 and its 200 day simple moving average is $66.97.

Utah Medical Products Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 3rd. Stockholders of record on Monday, December 16th will be issued a dividend of $0.305 per share. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 1.91%. The ex-dividend date of this dividend is Monday, December 16th. Utah Medical Products’s dividend payout ratio is 28.10%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.